Market Overview:
The global DNA sequencing in drug discovery market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing demand for personalized medicines, rising prevalence of chronic diseases, and technological advancements in DNA sequencing techniques. Based on type, the global DNA sequencing in drug discovery market is segmented into microarrays and polymerase chain reaction (PCR) techniques. The PCR technique segment is expected to grow at a higher CAGR during the forecast period owing to its advantages such as high accuracy and speed, ability to detect low-level mutations, and multiplexing capability. Based on application, the global DNA sequencing in drug discovery market is segmented into pharmaceuticals and other applications. The pharmaceuticals segment accounted for the largest share of the global DNA sequencing in drug discovery market in 2017 owing to rising demand for targeted therapies and personalized medicines across the globe. Other applications include diagnostics & biomarkers research, agricultural biotechnology & animal husbandry research etc.
Product Definition:
DNA sequencing is a technique used to determine the sequence of nucleotides in a DNA molecule. This information can be used to identify genes and other important features of the DNA molecule. Sequencing is essential for drug discovery because it allows scientists to identify potential targets for drugs and develop strategies for inhibiting or reversing the effects of disease-causing mutations.
Microarrays:
Microarrays Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Application (Drug Discovery, Diagnostics) And Segment Forecasts To 2020 -> The global microarrays market is expected to grow at a CAGR of XX% during the forecast period. Microarray technology has been evolving in the fields of drug discovery and diagnostics for several years.
Polymerase Chain Reaction (pcr) Techniques:
Polymerase chain reaction (PCR) is a technique used for repeated amplification of DNA. It works by using a thermostable polymerase that has the ability to bind to an initial DNA sequence and then amplify said sequence through the addition of nucleotides to the growing chain. The process can be stopped when additional base sequences are present in the product or when all desired sequences have been amplified.
Application Insights:
The pharmaceutical application segment accounted for the largest revenue share in 2017 and is anticipated to maintain its dominance over the forecast period. This can be attributed to factors such as an increase in demand for targeted drugs with a higher success rate and fewer side effects. Moreover, an increase in research activities pertaining to novel drug development is also expected to have a positive impact on market growth during the study period.
Other applications include areas such as personalized medicine and agriculture that are poised to witness significant growth owing to increasing public awareness about preventable diseases caused due largely by genetic mutations. In addition, growing investments from private players are also expected drive other segments over the forecast period which would resultantly contribute towards revenue generation across all applications during this time span.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a well-established research framework for drug discovery. Moreover, an increase in R&D investments by leading pharmaceutical companies is expected to drive this regional market over the forecast period. The U.S.-based companies are engaged in extensive drug development activities and have access to sophisticated technologies, which they employ for drug discovery purposes.
Asia Pacific region held a substantial revenue share in 2017 due to emerging economies such as China and India investing heavily into genomic medicine research programs at both domestic level as well as international levels with collaborative efforts from various organizations including WHO & PNUT Genomics Platform (WHOPP), International Human Genome Sequencing Consortium (IAGSC) among others).
Growth Factors:
- Increasing demand for personalized medicines
- Rising prevalence of chronic diseases
- Technological advancements in DNA sequencing platforms and bioinformatics tools
- Growing number of drug discovery collaborations between pharmaceutical companies and research institutes
- Proliferation of genomics-based diagnostic tests
Scope Of The Report
Report Attributes
Report Details
Report Title
DNA Sequencing In Drug Discovery Market Research Report
By Type
Microarrays, Polymerase Chain Reaction (pcr) Techniques
By Application
Pharmaceutical, Other
By Companies
Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Siemens Healthcare Diagnostics, Promega Corporation, Nanogen, Inc., GVK Biosciences Private Limited, Illumina, Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Beckman Coulter (Danaher Corporation), 454 Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global DNA Sequencing In Drug Discovery Market Report Segments:
The global DNA Sequencing In Drug Discovery market is segmented on the basis of:
Types
Microarrays, Polymerase Chain Reaction (pcr) Techniques
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific, Inc.
- Sigma-Aldrich Corporation
- Siemens Healthcare Diagnostics
- Promega Corporation
- Nanogen, Inc.
- GVK Biosciences Private Limited
- Illumina, Inc.
- Roche Diagnostics
- Bio-Rad Laboratories, Inc.
- Beckman Coulter (Danaher Corporation)
- 454 Life Sciences
Highlights of The DNA Sequencing In Drug Discovery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Microarrays
- Polymerase Chain Reaction (pcr) Techniques
- By Application:
- Pharmaceutical
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DNA Sequencing In Drug Discovery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DNA sequencing is a technique used in drug discovery to identify potential drug targets. DNA sequencing can be used to determine the sequence of specific genes or portions of genes. This information can then be used to guide the development of potential drugs that target these specific gene sequences.
Some of the major companies in the dna sequencing in drug discovery market are Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Siemens Healthcare Diagnostics, Promega Corporation, Nanogen, Inc., GVK Biosciences Private Limited, Illumina, Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Beckman Coulter (Danaher Corporation), 454 Life Sciences.
The dna sequencing in drug discovery market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 DNA Sequencing In Drug Discovery Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 DNA Sequencing In Drug Discovery Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 DNA Sequencing In Drug Discovery Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the DNA Sequencing In Drug Discovery Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global DNA Sequencing In Drug Discovery Market Size & Forecast, 2018-2028 4.5.1 DNA Sequencing In Drug Discovery Market Size and Y-o-Y Growth 4.5.2 DNA Sequencing In Drug Discovery Market Absolute $ Opportunity
Chapter 5 Global DNA Sequencing In Drug Discovery Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 DNA Sequencing In Drug Discovery Market Size Forecast by Type
5.2.1 Microarrays
5.2.2 Polymerase Chain Reaction (pcr) Techniques
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global DNA Sequencing In Drug Discovery Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 DNA Sequencing In Drug Discovery Market Size Forecast by Applications
6.2.1 Pharmaceutical
6.2.2 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global DNA Sequencing In Drug Discovery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 DNA Sequencing In Drug Discovery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America DNA Sequencing In Drug Discovery Analysis and Forecast
9.1 Introduction
9.2 North America DNA Sequencing In Drug Discovery Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America DNA Sequencing In Drug Discovery Market Size Forecast by Type
9.6.1 Microarrays
9.6.2 Polymerase Chain Reaction (pcr) Techniques
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America DNA Sequencing In Drug Discovery Market Size Forecast by Applications
9.10.1 Pharmaceutical
9.10.2 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe DNA Sequencing In Drug Discovery Analysis and Forecast
10.1 Introduction
10.2 Europe DNA Sequencing In Drug Discovery Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe DNA Sequencing In Drug Discovery Market Size Forecast by Type
10.6.1 Microarrays
10.6.2 Polymerase Chain Reaction (pcr) Techniques
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe DNA Sequencing In Drug Discovery Market Size Forecast by Applications
10.10.1 Pharmaceutical
10.10.2 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific DNA Sequencing In Drug Discovery Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific DNA Sequencing In Drug Discovery Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific DNA Sequencing In Drug Discovery Market Size Forecast by Type
11.6.1 Microarrays
11.6.2 Polymerase Chain Reaction (pcr) Techniques
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific DNA Sequencing In Drug Discovery Market Size Forecast by Applications
11.10.1 Pharmaceutical
11.10.2 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America DNA Sequencing In Drug Discovery Analysis and Forecast
12.1 Introduction
12.2 Latin America DNA Sequencing In Drug Discovery Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America DNA Sequencing In Drug Discovery Market Size Forecast by Type
12.6.1 Microarrays
12.6.2 Polymerase Chain Reaction (pcr) Techniques
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America DNA Sequencing In Drug Discovery Market Size Forecast by Applications
12.10.1 Pharmaceutical
12.10.2 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) DNA Sequencing In Drug Discovery Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) DNA Sequencing In Drug Discovery Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) DNA Sequencing In Drug Discovery Market Size Forecast by Type
13.6.1 Microarrays
13.6.2 Polymerase Chain Reaction (pcr) Techniques
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) DNA Sequencing In Drug Discovery Market Size Forecast by Applications
13.10.1 Pharmaceutical
13.10.2 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 DNA Sequencing In Drug Discovery Market: Competitive Dashboard
14.2 Global DNA Sequencing In Drug Discovery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific, Inc.
14.3.2 Sigma-Aldrich Corporation
14.3.3 Siemens Healthcare Diagnostics
14.3.4 Promega Corporation
14.3.5 Nanogen, Inc.
14.3.6 GVK Biosciences Private Limited
14.3.7 Illumina, Inc.
14.3.8 Roche Diagnostics
14.3.9 Bio-Rad Laboratories, Inc.
14.3.10 Beckman Coulter (Danaher Corporation)
14.3.11 454 Life Sciences